CANbridge Pharmaceuticals Inc. (HK:1228) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
CANbridge Pharmaceuticals Inc. has announced a change of auditors, with Ernst & Young resigning due to disagreements over audit fees and HLB Hodgson Impey Cheng Limited stepping in as the new auditor. The company’s board believes this switch will aid in cost control and reduce operating expenses, ensuring the transition will not impact the annual results for 2024.
For further insights into HK:1228 stock, check out TipRanks’ Stock Analysis page.